KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) EPS (Weighted Average and Diluted) (2016 - 2025)

Thermo Fisher Scientific's EPS (Weighted Average and Diluted) history spans 17 years, with the latest figure at $5.21 for Q4 2025.

  • For the quarter ending Q4 2025, EPS (Weighted Average and Diluted) rose 9.0% year-over-year to $5.21, compared with a TTM value of $17.74 through Dec 2025, up 7.32%, and an annual FY2025 reading of $17.74, up 7.32% over the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was $5.21 at Thermo Fisher Scientific, up from $4.27 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was $5.88 in Q2 2021, with the low at $3.32 in Q2 2023.
  • Average EPS (Weighted Average and Diluted) over 5 years is $4.34, with a median of $4.23 recorded in 2022.
  • Year-over-year, EPS (Weighted Average and Diluted) skyrocketed 198.48% in 2021 and then plummeted 40.82% in 2023.
  • Tracing TMO's EPS (Weighted Average and Diluted) over 5 years: stood at $4.17 in 2021, then fell by 3.84% to $4.01 in 2022, then grew by 4.74% to $4.2 in 2023, then rose by 13.81% to $4.78 in 2024, then rose by 9.0% to $5.21 in 2025.
  • Per Business Quant, the three most recent readings for TMO's EPS (Weighted Average and Diluted) are $5.21 (Q4 2025), $4.27 (Q3 2025), and $4.28 (Q2 2025).